Mostrar el registro sencillo del ítem
| dc.contributor.author | Osete, José-Miguel | |
| dc.contributor.author | García-Candel, Faustino | |
| dc.contributor.author | Fernández-Gómez, Francisco-José | |
| dc.contributor.author | Blanquer-Blanquer, Miguel | |
| dc.contributor.author | Atucha, Noemi-M | |
| dc.contributor.author | García-Estañ, Joaquín | |
| dc.contributor.author | Iyu, David | |
| dc.date.accessioned | 2025-11-24T12:28:54Z | |
| dc.date.available | 2025-11-24T12:28:54Z | |
| dc.date.issued | 2024-12 | |
| dc.identifier.citation | Osete JM, García-Candel F, Fernández-Gómez FJ, Blanquer M, Atucha NM, García-Estañ J, et al. TRAP-Induced Platelet Reactivity Is Inhibited by Omega-3 Fatty Acid-Derived Prostaglandin E3 (PGE3). Biomedicines. 16 de diciembre de 2024;12(12):2855. | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/22193 | |
| dc.description.abstract | Background: Prostaglandins are naturally occurring local mediators that can participate in the modulation of the cardiovascular system through their interaction with Gs/Gi-coupled receptors in different tissues and cells, including platelets. Thrombin is one of the most important factors that regulates platelet reactivity and coagulation. Clinical trials have consistently shown that omega-3 fatty acid supplementation lowers the risk for cardiovascular mortality and morbidity. Since omega-3 fatty acids are the main precursors of PGE3 in vivo, it would be relevant to investigate the effects of PGE3 on Thrombin Receptor Activating Peptide (TRAP-6)-induced platelet reactivity to determine the receptors and possible mechanisms of action of these compounds. Methods: We have measured platelet aggregation, P-selectin expression, and vasodilator-stimulated phosphoprotein (VASP) phosphorylation to evaluate platelet reactivity induced by TRAP-6 to determine the effects of PGE3 on platelet function. Results: We assessed the ability of DG-041, a selective prostanoid EP3 receptor antagonist, and of ONO-AE3-208, a selective prostanoid EP4 receptor antagonist, to modify the effects of PGE3. PGE3 inhibited TRAP-6-induced platelet aggregation and activation. This inhibition was enhanced in the presence of a Gi-coupled EP3 receptor antagonist and abolished in the presence of a Gs-coupled EP4 receptor antagonist. The effects of PGE3 were directly related to changes in cAMP, assessed by VASP phosphorylation. Conclusions: The general effects of PGE3 on human platelet reactivity are the consequence of a balance between activatory and inhibitory effects at receptors that have contrary effects on adenylate cyclase. These results indicate a potential mechanism by which omega-3 fatty acids underlie cardioprotective effects. | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/es/ | * |
| dc.title | TRAP-Induced Platelet Reactivity Is Inhibited by Omega-3 Fatty Acid-Derived Prostaglandin E3 (PGE3) | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 39767761 | |
| dc.relation.publisherversion | https://www.mdpi.com/2227-9059/12/12/2855 | |
| dc.identifier.doi | 10.3390/biomedicines12122855 | |
| dc.journal.title | Biomedicines | |
| dc.identifier.essn | 2227-9059 |